Hu Z, Jin W, Lou S, Zhang L, et al. Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China. Ren Fail 2025;47:2578413.
PMID: 41178160